<DOC>
	<DOC>NCT01184235</DOC>
	<brief_summary>The study examines actigraphic, observational, psychometric and associated repeated measurements obtained prior to and during psychopharmacological treatment.</brief_summary>
	<brief_title>Multidimensional Measurement of Psychopharmacological Treatment Response</brief_title>
	<detailed_description>Baseline actigraphic measurements, multi-symptom operationally defined observations and psychometric data will be established and repeated to measure treatment response. Additional biological and biometric measures that have potential to further characterize the cohorts under study or treatment response will be collected as practical and when possible.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders, Pervasive</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>Diagnosis of: Autism Spectrum Disorder Mood Disorder Attention Deficit Hyperactivity Disorder Unaffected First Degree Relative of Study Subject Anticipation of pharmacological intervention or current pharmacological intervention Inability to wear an actigraphy watch</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Circadian Disorders</keyword>
	<keyword>Autism Spectrum Disorders</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Executive Functioning</keyword>
	<keyword>Pediatric Mood Disorders</keyword>
</DOC>